WHO Advocates Lifestyle-First Approach to Combat Childhood Obesity Without Drugs or Surgery

The World Health Organization (WHO) has issued new global guidelines to address obesity among children and adolescents, strongly advising against the use of weight-loss injections and medication for children under 10 years old. Instead, experts emphasize that intervention should rely primarily on healthy nutrition and regular physical activity.

WHO officials warned that the long-term impacts of popular GLP-1 weight-loss medications on young bodies remain insufficiently researched. Consequently, such pharmaceuticals should only be considered for older adolescents when all non-pharmacological interventions fail. Bariatric surgery is similarly categorized as an absolute last resort—reserved exclusively for severe adolescent cases that show no improvement after six months of intensive conservative management.

The updated recommendations respond to a growing global crisis: current data shows that 400 million young people aged 5 to 19 carry excess weight, with 170 million living with clinical obesity. Despite regulatory approvals in the US and Europe allowing drugs like Wegovy and Saxenda for children as young as 6 to 12, the WHO stresses that sustainable solutions require fundamental family lifestyle transformations rather than reliance on medical prescriptions.